ALSP Orchid Acquisition I closed its IPO of 17.25 million units, including 2.25 million units issued to the underwriters through the exercise of their over-allotment option.
ALSP Orchid intends to pursue investments in North America and Singapore with an emphasis on life science companies developing assets and next-generation platform technologies with broad applicability.
Stifel, Nicolaus and Nomura Securities were joint book-running managers of the offering. Read more.
